Alan Doucette is listed as a director on 1 SEC Form D filing by 1 issuer in Aug 2019: Proteoform Scientific Inc. (Halifax, Nova Scotia, Canada (as filed: A5) — biotechnology — 2019; $595K reported sold to 10 investors).
What this means One deal on file with the SEC, filed Aug 2019. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside ALI RIAZ (1 shared filing), Kevin Buchan (1 shared filing), Neil Smith (1 shared filing) and PETER HICKEY (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Alan. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Alan Doucette and found 2 differences: Form D filed 18 days after the first sale; No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.